M&A Deal Summary

Takara Bio USA Holdings Acquires Rubicon Genomics

On December 15, 2016, Takara Bio USA Holdings acquired life science company Rubicon Genomics from The BroadOak Fund

Acquisition Highlights
  • This is Takara Bio USA Holdings’ 1st transaction in the Life Science sector.
  • This is Takara Bio USA Holdings’ 1st transaction in the United States.
  • This is Takara Bio USA Holdings’ 1st transaction in Michigan.

M&A Deal Summary

Date 2016-12-15
Target Rubicon Genomics
Sector Life Science
Buyer(s) Takara Bio USA Holdings
Sellers(s) The BroadOak Fund
Deal Type Add-on Acquisition
Advisor(s) BroadOak Capital Partners (Financial)
Honigman (Legal)

Target

Rubicon Genomics

Ann Arbor, Michigan, United States
Rubicon Genomics, Inc. is involved in the development of amplification tools for genetic research and clinical applications.

Search 201,292 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Takara Bio USA Holdings

Mountain View, California, United States

Category Company
Founded 1984
Sector Medical Products
Employees190
DESCRIPTION

Takara Bio USA Holdings, Inc. is a provider of kits, reagents, and services that help researchers explore questions about gene discovery, regulation, and function.


DEAL STATS #
Overall 1 of 1
Sector (Life Science) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Michigan) 1 of 1
Country (United States) 1 of 1
Year (2016) 1 of 1

Seller(S) 1

DESCRIPTION

The BroadOak Fund is the investment affiliate of life science focused investment bank BroadOak Capital Partners. The BroadOak Fund provides growth capital to life sciences tools and service providers that have achieved a level of commercial success. The BroadOak Fund is based in Bethesda, Maryland.


DEAL STATS #
Overall 4 of 6
Sector (Life Science) 3 of 5
Type (Add-on Acquisition) 4 of 5
State (Michigan) 1 of 1
Country (United States) 4 of 6
Year (2016) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2016-03-02 LabConnect

Johnson City, Tennessee, United States

LabConnect is a provider of global central laboratory services, including routine and esoteric laboratory testing, kit building, sample management, biorepository and scientific support services for biopharmaceutical, medical device and contract research organizations. LabConnect was founded in 2002 and is based in Johnson City, Tennessee.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2018-01-08 BioNex Solutions

San Jose, California, United States

BioNex Solutions is a privately funded life science company focused on providing customers with advanced technology systems for laboratory automation and liquid handling. BioNex Solutions was founded in 2009 and is based in San Jose, California.

Buy -